TY - JOUR
T1 - A truncation in the RYR1 gene associated with central core lesions in skeletal muscle fibres.
AU - Rossi, Daniela
AU - De Smet, Patrick
AU - Lyfenko, Alla
AU - Galli, Lucia
AU - Lorenzini, Stefania
AU - Franci, Daniela
AU - Petrioli, Francesco
AU - Orrico, Alfredo
AU - Angelini, Corrado
AU - Tegazzin, Vincenzo
AU - Dirksen, Robert
AU - Sorrentino, Vincenzo
PY - 2007/2
Y1 - 2007/2
N2 - A novel single-nucleotide deletion in exon 100 of the RYR1 gene, corresponding to deletion of nucleotide 14,510 in the human RyR1 mRNA (c14510delA), was identified in a man with malignant hyperthermia and in his two daughters who were normal for malignant hyperthermia. This deletion results in a RyR1 protein lacking the last 202 amino acid residues. All three subjects heterozygotic for the mutated allele presented with a prevalence of type 1 fibres with central cores, although none experienced clinical signs of myopathy. Expression of the truncated protein resulted in non-functional RYR1 calcium release channels. Expression of wild-type and RyR1(R4836fsX4838) proteins resulted in heterozygotic release channels with overall functional properties similar to those of wild-type RyR1 channels. Nevertheless, small differences in sensitivity to calcium and caffeine were observed in heterotetrameric channels, which also presented an altered assembly/stability in sucrose-gradient centrifugation analysis. Altogether, these data suggest that altered RYR1 tetramer assembly/stability coupled with subtle chronic changes in Ca2+ homoeostasis over the long term may contribute to the development of core lesions and incomplete malignant hyperthermia susceptibility penetrance in individuals carrying this novel RYR1 mutation.
AB - A novel single-nucleotide deletion in exon 100 of the RYR1 gene, corresponding to deletion of nucleotide 14,510 in the human RyR1 mRNA (c14510delA), was identified in a man with malignant hyperthermia and in his two daughters who were normal for malignant hyperthermia. This deletion results in a RyR1 protein lacking the last 202 amino acid residues. All three subjects heterozygotic for the mutated allele presented with a prevalence of type 1 fibres with central cores, although none experienced clinical signs of myopathy. Expression of the truncated protein resulted in non-functional RYR1 calcium release channels. Expression of wild-type and RyR1(R4836fsX4838) proteins resulted in heterozygotic release channels with overall functional properties similar to those of wild-type RyR1 channels. Nevertheless, small differences in sensitivity to calcium and caffeine were observed in heterotetrameric channels, which also presented an altered assembly/stability in sucrose-gradient centrifugation analysis. Altogether, these data suggest that altered RYR1 tetramer assembly/stability coupled with subtle chronic changes in Ca2+ homoeostasis over the long term may contribute to the development of core lesions and incomplete malignant hyperthermia susceptibility penetrance in individuals carrying this novel RYR1 mutation.
UR - http://www.scopus.com/inward/record.url?scp=34248378239&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34248378239&partnerID=8YFLogxK
U2 - 10.1136/jmg.2006.043794
DO - 10.1136/jmg.2006.043794
M3 - Article
C2 - 17293538
AN - SCOPUS:34248378239
SN - 0022-2593
VL - 44
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
IS - 2
ER -